Ivabradine Tablet 7.5 mg Ivabeat

Trade Name: Ivabeat 7.5

Manufacturer: Cipla Ltd

Presentation: Tablet

Strength: 7.5mg


What is Ivabradine Tablet used for?

Adults with chronic heart failure are given Ivabradine Tablet to lower their chance of hospitalization due to worsening heart failure. It is also used to treat stable heart failure in children aged 6 months and older who have symptoms caused by an enlarged heart (dilated cardiomyopathy).

When should ivabradine be used?

Ivabradine is a drug that is used to treat certain adults with heart failure (a condition in which the heart is unable to pump enough blood to the rest of the body) in order to reduce the chance of their condition worsening and requiring hospital treatment.

Does ivabradine increase blood pressure?

In conclusion, lowering heart rate with ivabradine does not raise central aortic blood pressure and is related to a significant increase in diastolic perfusion time and a better myocardial perfusion index.

How long can you take ivabradine?

In clinical practice, long-term treatment with ivabradine for 12 months in patients with chronic heart failure: Symptoms, quality of life, and hospitalizations are all affected.

Is ivabradine a beta-blocker?

Ivabradine reduces HR in a different way than beta-blockers, and it’s been recommended in European Society of Cardiology guidelines to lower the risk of CHF hospitalization and cardiovascular death in symptomatic patients with EF 35 percent who are in sinus rhythm and have a resting HR of 70 beats per minute despite having a resting HR of 70 beats per minute despite having a resting HR of 70 beats per minute despite having a resting HR of 70 beats per.

Can ivabradine treat tachycardia?

Messages to take home. Ivabradine acts by inhibiting the l(f) current in the sinus node, lowering heart rate without compromising hemodynamics in individuals with extremely symptomatic inappropriate sinus tachycardia who do not respond to beta-blockers or verapamil treatment.

Is ivabradine used for angina?

Ivabradine is a well-tolerated and effective anti-anginal drug, according to the available data, and it is indicated as second-line therapy for angina relief in guidelines. Recent clinical trials using ivabradine, on the other hand, have failed to show prognostic improvement, raising safety concerns. To know more click here.

We are a global wholesaler and exporter based in India, with operations in more than five countries including the United Arab Emirates, Oman, Qatar, Saudi Arabia, Myanmar, and others. If you’re looking for a specific product or brand, go here.